|
|
|
| The 4th mRNA Process Development & CMC Summit returns to Boston (September 23-25) as the world’s only flagship forum dedicated to overcoming bottlenecks and help mRNA therapeutic and vaccine developers deliver safer and more effective mRNA drugs to patients. Featuring insights from Sanofi, GSK, Moderna, AstraZeneca, CSL, BioNTech, CEPI, US Pharmacopeia, CureVac, Editas Medicines, and many more! |
|
|
|
|
By Drug Delivery Leader: Sit and Deliver | In this videocast, host Tom von Gunden talks with Merck VP of Pharmaceutical Sciences and Clinical Supply Allen Templeton about formulation and delivery device considerations across a range of molecule types and various routes of administration including oral, injectable, and inhalation. | |
|
|
All Of Us Need To Be Rooting For The FDA | By Steven Grossman, FDA Matters | In light of FDA leadership changes and operational updates, FDA Matters' Steven Grossman asks us all to slow down and consider why we should be cheering on, not tearing down, the present-day FDA. |
|
|
|
| Is My Molecule Suitable For An Orally Disintegrating Tablet? | White Paper | By Susan Banbury, Ph.D., Adina Dîrlea; Charli Smardon, Catalent and Simon A. Lawton, MD, ALK | Innovations in drug delivery formats are enabling more patient-centric treatments and helping to boost patient compliance. Learn about the advances being developed to expand ODT technology. |
|
|
| Flexibility And Capability In Pre-Filled Syringes | White Paper | Curia | Examine the inherent benefits of PFS and how they relate to the delivery of drugs, such as biologics and vaccines, and how a partnership with a flexible CDMO is the key to success. |
|
|
|
|
|
|
|
|
|
|
.png){kind=logo}
